Quick Links

Message from Head

Message from the Head

Since its early beginnings in the 1890s, our Department has an esteemed history of providing outstanding service

Read more



Before there was a UIC College of Medicine, there was the College of Physicians and Surgeons, known colloquially as

Read more


Sample image

Learn about the institutes of Department of Psychiatry

Read more


Values Statement


EXCELLENCE EVERYWHERE — in research, education and clinical work

Read more

Ligand Directed Signaling at Delta Opioid Receptors

Activation of the delta opioid receptor has been shown to produce pain-relief, and reduce anxiety and depression. For these reasons agonist to this receptor are currently being developed for clinical use.  However, a deterrent to the development of these compounds, is that some delta opioid receptor agonists also produce convulsions, an adverse effect that has been observed across species.  At the moment there is no way to predict whether a novel agonist will have this property. The goal of this work is to determine the mechanism that accounts for this difference between agonists that bind to the same receptor.  These studies have important biological implications, and ultimately would increase the potential for delta opioid receptor agonists as novel drug therapies.

Amynah Pradhan, PhD


  1. Ambulatory Clinic:
    Neuropsychiatric Insitute
    912 S. Wood Steet, Chicago, IL 60612
  2. UIC Hospital
    1740 W Taylor St, Chicago, IL 60612
  3. Institute for Juvenile Research
    1747 W. Roosevelt Rd, Chicago, IL 60608
  4. Psychiatric Institute
    1601 W. Taylor St.Chicago, IL 60612

For driving instructions Click Here

You are here: Home RESEARCH Additional Research Projects Ligand Directed Signaling at Delta Opioid Receptors